8 Einträge gefunden

1. Palbociclib in Acute Leukemias With KMT2A-rearrangement: Results of AMLSG 23-14 Trial

   1. Gaidzik, Verena I
   2. Paschka, Peter
   3. Schlenk, Richard F
   4. Weber, Daniela
   5. Fröhling, Stefan
   6. Krämer, Alwin
   7. Wäsch, Ralph

   2023 - Forschungsinformationssystem des UKE - frei zugänglich
2. Corrigendum to "Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'" [European Journal of Cancer 135 (2020) 1-7]

   1. Benedikt Westphalen, C
   2. Bokemeyer, Carsten
   3. Büttner, Reinhard
   4. Fröhling, Stefan
   5. Gaidzik, Verena I
   6. Glimm, Hanno
   7. Hacker, Ulrich T

   2022 - Forschungsinformationssystem des UKE
3. Cluster of differentiation 33 single nucleotide polymorphism rs12459419 is a predictive factor in patients with nucleophosmin1 mutated acute myeloid leukemia receiving gemtuzumab ozogamicin

   1. Teich, Katrin
   2. Krzykalla, Julia
   3. Kapp-Schwoerer, Silke
   4. Gaidzik, Verena I
   5. Schlenk, Richard F
   6. Paschka, Peter
   7. Weber, Daniela

   2021 - Forschungsinformationssystem des UKE
4. Conceptual framework for precision cancer medicine in Germany: Consensus statement of the Deutsche Krebshilfe working group 'Molecular Diagnostics and Therapy'

   1. Westphalen, Benedikt C
   2. Bokemeyer, Carsten
   3. Büttner, Reinhard
   4. Fröhling, Stefan
   5. Gaidzik, Verena I
   6. Glimm, Hanno
   7. Hacker, Ulrich T

   2020 - Forschungsinformationssystem des UKE
5. Impact of gemtuzumab ozogamicin on MRD and relapse risk in patients with NPM1-mutated AML: results from the AMLSG 09-09 trial

   1. Kapp-Schwoerer, Silke
   2. Weber, Daniela
   3. Corbacioglu, Andrea
   4. Gaidzik, Verena I
   5. Paschka, Peter
   6. Krönke, Jan
   7. Theis, Frauke

   2020 - Forschungsinformationssystem des UKE
6. Gemtuzumab Ozogamicin in NPM1-Mutated Acute Myeloid Leukemia: Early Results From the Prospective Randomized AMLSG 09-09 Phase III Study

   1. Schlenk, Richard F
   2. Paschka, Peter
   3. Krzykalla, Julia
   4. Weber, Daniela
   5. Kapp-Schwoerer, Silke
   6. Gaidzik, Verena I
   7. Leis, Claudia

   2020 - Forschungsinformationssystem des UKE
7. Measurable residual disease monitoring in acute myeloid leukemia with t(8;21)(q22;q22.1): results from the AML Study Group

   1. Rücker, Frank G
   2. Agrawal, Mridul
   3. Corbacioglu, Andrea
   4. Weber, Daniela
   5. Kapp-Schwoerer, Silke
   6. Gaidzik, Verena I
   7. Jahn, Nikolaus

   2019 - Forschungsinformationssystem des UKE
8. Adding dasatinib to intensive treatment in core-binding factor acute myeloid leukemia-results of the AMLSG 11-08 trial

   1. Paschka, Peter
   2. Schlenk, Richard F
   3. Weber, Daniela
   4. Benner, Axel
   5. Bullinger, Lars
   6. Heuser, Michael
   7. Gaidzik, Verena I

   2018 - Forschungsinformationssystem des UKE